0 followers
By leveraging their immunology expertise, HCW is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.
Hing C. Wong
Kura Oncology
18 followers
REVOLUTION Medicines
5 followers
Relay Therapeutics
1 follower
Volastra
1 follower
Eikon Therapeutics
1 follower
Scribe Therapeutics
1 follower
Gilead Sciences
128 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
GRAIL
27 followers
Explore companies